{{Rsnum
|rsid=12726652
|Chromosome=1
|position=106889954
|Orientation=plus
|GMAF=0.2984
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.5 | 26.8 | 68.8
| HCB | 16.2 | 47.8 | 36.0
| JPT | 10.6 | 43.4 | 46.0
| YRI | 30.6 | 53.1 | 16.3
| ASW | 12.3 | 50.9 | 36.8
| CHB | 16.2 | 47.8 | 36.0
| CHD | 22.9 | 46.8 | 30.3
| GIH | 4.0 | 41.6 | 54.5
| LWK | 15.6 | 43.1 | 41.3
| MEX | 0.0 | 16.1 | 83.9
| MKK | 15.5 | 49.7 | 34.8
| TSI | 2.0 | 28.4 | 69.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=5E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}